(Abst.) Age and treatment class modify inflammatory risk after DMT discontinuation in older people with MS on: September 15, 2026, 03:16:14 pm #1 From PubMed (September 15, 2026)--"Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older peoplel with MS": pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
